Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vitamin A-dependent zinc-binding protein (ZnBP) is an 83 kDa acidic glycoprotein primarily located in the ileal mucosa that is essential for the intestinal absorption of zinc. Its synthesis is strictly regulated by Vitamin A (retinol), which acts as a molecular inducer to ensure adequate levels of the protein are available for zinc transport across the intestinal epithelium. In states of Vitamin A deficiency, the production of ZnBP is significantly reduced, leading to impaired zinc uptake and subsequent secondary zinc deficiency, even when dietary zinc intake is otherwise sufficient. The protein exhibits high binding specificity for zinc ions over other divalent cations such as calcium or copper. This target is a critical component in the synergistic relationship between Vitamin A and zinc, making it a focal point for nutritional interventions and the study of malabsorption syndromes, growth retardation, and immune system maintenance.
Vitamin A-mediated induction of protein synthesis to facilitate intestinal zinc transport.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vitamin A-dependent zinc-binding protein (ZnBP).